Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/formoterol in mild to moderate COPD exacerbations
NCT00239278Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jan 2001; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00239278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239278.